The Role of Neck Dissection After Chemoradiotherapy for Oropharyngeal Cancer With Advanced Nodal Disease
Open Access
- 1 February 2001
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 127 (2) , 135-139
- https://doi.org/10.1001/archotol.127.2.135
Abstract
Objective To analyze and compare the effectiveness of sequential platinum-based chemotherapy and radiotherapy with and without selective neck dissection in patients with N2a and greater stage node-positive squamous cell carcinoma of the oropharynx. Design Nonrandomized controlled trial. Setting Tertiary referral center. Patients Sixty-six patients with squamous cell carcinoma of the oropharynx staged N2a or greater. Interventions Platinum-based induction chemotherapy followed by definitive radiation therapy; and selective neck dissections 6 to 10 weeks following the completion of radiation therapy in patients with radiographic evidence suggesting residual neck disease. Main Outcome Measures Locoregional recurrence and disease-free survival. Results Of 66 patients, 24 (36%) had complete responses in the primary local tumor (oropharynx) and regional disease (neck nodes), as assessed clinically and radiographically. These patients had lower rates of locoregional recurrence than did patients showing no or partial responses, but the differences were not significant (P>.05). Of 18 patients undergoing neck dissection, 10 (56%) had pathological evidence of residual tumor. Patients showing a complete response of regional and neck disease had significantly improved disease-specific and overall survival (P = .01 for both) compared with patients showing no or partial responses of their neck disease. Patients with no or partial responses who underwent neck dissections had significantly improved overall survival compared with similar patients who did not undergo neck dissections (P = .002). Conclusions Even in patients with bulky nodal disease, a complete response in the neck to sequential chemotherapy and radiotherapy may indicate that neck surgery is not necessary for good locoregional control and improved disease-free survival. Neck dissection is recommended for patients with no or partial radiographic responses.Keywords
This publication has 8 references indexed in Scilit:
- Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2Cancer Immunology, Immunotherapy, 1998
- Management of the clinically positive neck in organ preservation for advanced head and neck cancerThe American Journal of Surgery, 1998
- Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck CancerNew England Journal of Medicine, 1998
- Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossaInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapyHead & Neck, 1996
- Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancerThe American Journal of Surgery, 1995
- The management of the clinically positive neck as part of a larynx preservation approachInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Definitive radiotherapy for squamous cell carcinoma of the tonsillar fossaInternational Journal of Radiation Oncology*Biology*Physics, 1989